This evidence gap reflects several factors including lack of pharmaceutical company funding (peptides not patentable, unprofitable versus proprietary drugs), regulatory challenges (FDA approval process expensive), and peptide use primarily occurring outside mainstream medicine in research chemical/biohacking communities
With consistent use, you will notice a reduction in hyperpigmentation, a smoother texture, and a more youthful appearance
At minimum: Outcomes Weight trend (weekly average) Waist circumference Body composition if available (DEXA, BIA with consistency) Strength markers (basic lifts, grip strength, functional tests) Safety Blood pressure + resting HR A1c and fasting glucose (more often if diabetes) CMP (liver/kidney) Lipids (periodic) If manipulating GH/IGF-1 signaling: IGF-1 (and clinical context matters) Stop criteria Persistent tachycardia, edema, severe fatigue, worsening glycemia, abnormal labs, or new symptoms you cant explain The what to ask your clinic questions (high signal, low fluff) If a clinic recommends a peptide stack, ask: What is the problem were solving, in one sentence
Two single-nucleotide polymorphisms identified in the GABRG3 gene exhibit significant linkage disequilibrium with ASD, suggesting that GABRG3 or its neighboring genes may constitute genetic risk loci for ASD (66)
Water stress was imposed up to 55 DAS
In addition, BP extract repressed 31.78% of lipid oxidation of beef burgers at the end of the analyses (59)
